CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

203 hedge funds and large institutions have $3.76B invested in Crinetics Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 78 increasing their positions, 55 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+22
Holders Change %
+12.15%
% of All Funds
2.94%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.19%
New
50
Increased
78
Reduced
55
Closed
28
Calls
$34.1M
Puts
$28.1M
Net Calls
+$6.03M
Net Calls Change
-$4.54M

Top Buyers

1
EC
EcoR1 Capital
California
$195M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
$232M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$92.5M
4
AG
Artal Group
Luxembourg
$65.1M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$179M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
$28.7M
2
APM
Avidity Partners Management
Texas
$0
3
VPC
Vestal Point Capital
New York
$0
4
State Street
State Street
Massachusetts
$152M
5
FLSM
Frazier Life Sciences Management
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SIM
226
Sandia Investment Management
Massachusetts
– -$106K -2,990 Closed
A
227
AJOVista
Massachusetts
– -$58K -1,630 Closed
CG
228
Cutler Group
California
– -$42K -1,200 Closed
QL
229
Quarry LP
New York
– -$35.6K -1,000 Closed
WTG
230
West Tower Group
Virginia
– -$6.26K -176 Closed
6 7 8 9
10